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axles in branched [4]pseudorotaxane formation.
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2Tris-N-alkylpyridinium-functionalised cyclotriguaiacylene hosts as
axles in branched [4]pseudorotaxane formation
A series of [4]pseudorotaxanes composed of three-way axle threads based on the
cyclotriguaiacylene family of crown-shaped cavitands and three threaded
macrocyclic components has been achieved. These exploit the strong affinity for
electron-poor alkyl-pyridinium units to reside within the electron-rich cavity of
macrocycles, in this case dimethoxypillar[5]arene (DMP). The branched
[4]pseudorotaxane assemblies {(DMP)3Â/`3+,where L = N-alkylated derivatives
of the host molecule (±)-tris-(isonicotinoyl)cyclotriguaiacylene, were
characterised by NMR spectroscopy and mass spectrometry, and an energy-
minimised structure of {(DMP)3Âtris-(N-propyl-
isonicotinoyl)cyclotriguaiacylene)}3+ was calculated. Crystal structures of N-
ethyl-isonicotinoyl)cyclotriguaiacylene hexafluorophosphate and N-propyl-
isonicotinoyl)cyclotriguaiacylene hexafluorophosphate each show ‘hand-shake’
self-inclusion motifs occurring between the individual cavitands.
Keywords: mechanically interlocked molecules; pillar[5]arene;
cyclotriveratrylene
Introduction
Mechanically interlocked molecules have attracted great interest, both as
examples of interesting chemical architectures and as the control of motion within them
may lead to applications in molecular machinery.1,2 Examples include nanoscopic
stimuli-responsive molecular shuttles,3 molecular elevators,4muscle prototypes5 and,
most recently, a molecular pulley.6 Mechanically interlocked molecules, such as
catenanes and rotaxanes, are characterised by mechanical bonds where interlocking of
molecular components with no covalent chemical bonds between them occurs. A
rotaxane is composed of an axle-like component which threads through a macrocyclic
wheel component with de-threading prevented by bulky end groups on the axle.2
3Threading is often achieved through the manipulation of molecular recognition
LQWHUDFWLRQVEHWZHHQWKHFRPSRQHQWVZKHUHHOHFWURVWDWLFLQWHUDFWLRQVʌʌVWDFNLQJDQG
hydrogen bonding, etc. act to orient the individual components favourably prior to the
mechanical bond formation. A pseudorotaxane is often a precursor to a rotaxane and has
no physical barrier to de-threading. A common molecular recognition motif that is
employed for pseudorotaxanes and rotaxanes is the combination of a positively charged
alkyl-pyridinium – usually in the form of a bis-paraquat or alkane-linked
bis(pyridinium) –with an electron-rich macrocyclic host such as a dibenzocrown ether
3,7 or, more recently, with pillar[5]arene.8-12 Pillararenes have been extensively
researched since their discovery in 2007.8 Their composition is similar to that of a
calixarene, however the 1,4-dimethoxybenzene units are bridged at the 2- and 5-
positions as opposed to the 2- and 6-positions.9 The inner cavity of pillar[5]arene is ca.
5 Å and electron rich,9 making it making it well-suited for the complexation of shape-
specific and electron-poor guest molecules.
Molecular hosts such as crown ethers, calixarenes, cucurbiturils and pillararenes
have been frequently employed as the comprise the wheel component of
pseudorotaxanes or rotaxanes.2 Here, however, we report the use of a functionalised
molecular host as an axle component in the formation of [4]pseudorotaxanes. Branched
[4]pseudorotaxanes and rotaxanes have been previously reported with multi-armed axle
components based either on a substituted 1,3,5-benzene 13 or a boroxine core,14 and also
with a tritopic wheel component.15 Here we utilise the pyramidal-shaped host
cyclotriguaiacylene as the scaffold for the branched tritopic axle, and combine with
pillar[5]arene as the wheel component. Cyclotriguaiacylene (CTG) is a chiral host
molecule that forms part of the cyclotriveratrylene family, Figure 1.16 The hydroxyl
groups are easily functionalised, and there is a rich chemistry of tritopic CTG extended-
4arm CTG derivatives that have found great utility in host-guest chemistry and in the
construction of both organic and metal-organic cages and assemblies.16-18 There are few
examples of molecular hosts being used as structured branched axles for
pseudorotaxane or rotaxane formation, the best known are the tetra[2]rotaxanes reported
by Böhmer and co-workers which are capsule-like heterodimers with urea-axle
functionalisation on one calix[4]arene.19
Figure 1: Enantiomers of cyclotriguaiacylene
Results and Discussion
Tritopic branched-axle species were synthesised through the N-alkylation of (±)-
tris-(isonicotinoyl)cyclotriguaiacylene. Tris-(isonicotinoyl)cyclotriguaiacylene has been
previously reported as a ligand for crystalline coordination polymers 20,21 and cage-
species.18 N-alkylation was achieved through the reaction of tris-
(isonicotinoyl)cyclotriguaiacylene with an excess of the appropriate alkyl bromide in
the presence of KI, to give cationic cavitand molecules with three N-ethyl-pyridinium
(L13+), N-propyl-pyridinium (L23+), N-butyl-pyridinium (L33+) and N-octyl-pyridinium
(L43+) moieties in good yields, Scheme 1. Finkelstein conditions were used, employing
sub-stoichiometric KI as the nucleophilic catalyst, which rendered the desired N-alkyl-
pyridinium compounds as a mixture of bromide and iodide salts. The halide counter-
anions were exchanged for hexafluorophosphate in order to improve the solubility of
these charged compounds in common organic solvents, Scheme 1.
5Scheme 1. Synthesis of tris-(N-alkyl-isonicotinoyl)cyclotriguaiacylene species and
subsequent [4]pseudorotaxane formation ([4]PR) with dimethoxypillar[5]arene.
Single crystals suitable for X-ray structural analysis were obtained for the PF6-
salts of (±)-tris-(N-ethyl-isonicotinoyl)cyclotriguaiacylene L13+ and (±)-tris-(N-propyl-
isonicotinoyl)cyclotriguaiacylene L23+, with the structure of the former determined
using data from synchrotron radiation. The structure of compound L1Â3)6 was solved
in space group C2/c and consists of one L13+ cation in the asymmetric unit. The L13+
cations form self-inclusion pairs in the solid state, where an ethyl group of one cation
behaves as a guest species for an adjacent cation and vice versa to form a “hand-shake”
motif, Figure 2b. Within the pair the terminal propyl -CH3 groups are directed almost
exactly over the centre of the cavitand’s molecular cavities. This hand-shake motif is
6commonly seen for cyclotriguaiacylene derivatives,22 as well as for other types of bowl-
shaped host molecules.23 In this case, however, the hand-shake is homochiral rather than
occurring between enantiomeric pairs which is the more common observation. The
WHUPLQDOPHWK\OJURXSVLWVLQWKHFDYLW\DW&ÂÂÂDURPDWLFULQJFHQWURLGVHSDUDWLRQV
between 3.57 and 4.16 Å. A notable aspect of this association is that it is occurring
between cations, albeit with an 8.3 Å separation between the pyridinium N-atoms.
Within the lattice there are even closer associations between N-ethyl-pyridinium
moieties of adjacent cations, Figure 2c, with pairwise CmethylÂÂÂDURPDWLFULQJFHQWURLG
separation of 3.74 Å. The cations account for ca. 50% of the unit cell volume, (see
supplementary information for additional figures) and the crystal lattice also contains
PF6- anions and is likely to contain solvent which could not be located in the difference
map due to weak diffraction.
7Figure 2. From the X-ray structure of L1Â3)6. (a) L13+ cation of the asymmetric unit;
(b) hand-shake pair of cations in space-filling mode, highlighting the manner in which
WKHHWK\OJURXSVDUHGLUHFWHGLQWRWKHFDYLW\RIDQDGMDFHQWKRVWFSDLUZLVH&+ÂÂÂS
interaction between N-ethyl-pyridinium groups.
The structure of complex L2Â3)6Â&+3&1Â+2O) was solved in space group
C2/c and the asymmetric unit comprises two enantiomers of L23+, one of which was
refined as disordered (see supplementary material), four acetonitrile positions,
8disordered water and ordered and disordered PF6- positions. As for L1Â3)6 the cations
form self-inclusion motifs. However, here a tetrameric rather than pair-wise association
is observed. Each L23+ cation acts as a host for one N-propyl-pyridinium group of an
adjacent L23+ cavitand of opposite chirality, and one of its three N-propyl-pyridinium
groups occupies the guest position for a further L23+ host, also of opposite chirality.
These associations lead to a cyclic tetrameric arrangement, Figure 3b. Here it is the D-
CH2- group rather than the terminal methyl that forms the host-guest association with
WKHFDYLWDQGERZODWGLVWDQFHVLQGLFDWLYHRIZHDN&+ÂÂÂSK\GURJHQERQGLQJ&ÂÂÂULQJ
centroid separations between 3.49 and 3.84 Å). Packing of the L23+ cavitand molecules
creates circular channels which are occupied by PF6- and solvent molecules (see
supplementary information).
9Figure 3. From the X-ray structure of L2Â3)6Â&+3&1Â+2O). (a) One L23+ cation;
(b) tetrameric hand-shake association with different L23+ enantiomers in different
shadings. Disordered propyl and N-propyl-pyridinium groups shown in a single
position, and hydrogen atoms omitted for clarity.
[4]Pseudorotaxane formation using the tris-(N-alkylated-
LVRQLFRWLQR\OF\FORWULJXDLDF\OHQHFDYLWDQGV/Â3)6, where L = L1-L4, was investigated
using dimethoxypillar[5]arene (DMP) as the macrocyclic wheel component. For each
system the L3+ axle was dissolved in d3-MeCN, and a solution containing three
equivalents of dimethoxypillar[5]arene in d-chloroform was added. The solutions were
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heated gently to ensure full dissolution of the components, then cooled before 1H NMR
spectroscopy and mass spectrometry were employed to confirm the formation of the
[4]pseudorotaxane associations in solution, Scheme 1.
In all cases electrospray mass spectrometry (ES-MS) gave excellent evidence of
formation of the [4]pseudorotaxane species {(DMP)3ÂL1)}3+ (= [4]PR13+ ),
{(DMP)3ÂL2)}3+ (= [4]PR23+), {(DMP)3ÂL3)}3+ (= [4]PR33+), and {(DMP)3ÂL4)}3+
(= [4]PR43+). Mass spectrometry of the solutions of the 3:1 DMP:cavitand axle
mixtures clearly show peaks corresponding to the mass of one cavitand axle combined
with three dimethoxypillar[5]arene macrocycles, namely: [4]PR13+ m/z = 1020.7910,
[4]PR23+ m/z = 1035.1386, [4]PR33+ m/z = 1049.4812, [4]PR43+ m/z = 1105.2189. All
spectra also have m/z peaks corresponding to the unthreaded L3+ species. The high
resolution mass spectrum obtained for the 3:1 mixture of DMP and L3Â3)6 is shown in
Figure 4. As well as the peak corresponding to [4]PR33+, it shows a series of 3+ peaks
corresponding to two, one and no DMP macrocycles threaded to the L33+ cavitand, and
shows no other products of self-assembly. The spectrum obtained for DMP and L4Â3)6
shows a similarly simple pattern of {(DMP)nÂL4)}3+ species where n = 0-3 (see
supplementary information). The spectra for the mixtures of DMP with L1Â3)6 or
L2Â3)6 are more complicated (see supplementary material). They show a variety of
charge states where one or two PF6- counter-anions are associated with the cation, for
example the species {[4]PR2Â3)6}2+ (m/z 1625.1895) is observed, along with the
partially threaded{(DMP)2ÂL2Â3)6}2+DQG^'03ÂL2Â3)6}2+ species.
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Figure 4. High-resolution Electrospray Mass spectrum of CD3CN/CDCl3 solution of
1:3 L4Â3)6 and DMP, showing formation of {(DMP)3ÂL4}3+ (= [4]PR43+) at m/z
1105.2059 (calc 1105.2157), along with {(DMP)2ÂL4}3+ at m/z 854.7674 (calc
^'03ÂL4}3+ at m/z 604.6564 (calc 604.6543), and L43+ at m/z 354.2083
(calc 354.2064).
1H NMR studies also support formation of the [4]pseudorotaxane species
[4]PR13+ - [4]PR43+ with chemical shifts and through-space interactions observed
consistent with those previously reported for other pillar[5]arene-alkyl-pyridinium
systems.8,12 In all cases the cavitand retained C3-symmetry in solution and the
pyridinium and alkyl protons of the cavitand axles showed chemical shift changes
indicative of encapsulation by the dimethyoxy-pillar[5]arene macrocycles, Figure 5. In
[4]PR13+, Figure 5a, significant upfield shifts were observed for the N-CH2ĮSURWRQVRI
the ethyl chains (Hi) with a shift of 0.22 ppm, whilst the terminal CH3 (Hh) shows a
smaller shift of 0.14 ppm. The ortho-pyridyl hydrogen environment (Ha) at 8.92 ppm
shows a much larger upfield shift of 0.49 ppm, indicating that those protons experience
significant shielding from the aromatic ring, whilst the meta-hydrogen environment (Hb)
shows little movement (0.07 ppm). Instead it broadens out into a singlet and this loss of
12
splitting has been observed in other systems.8,10 Similar shifts are observed for [4]PR23+
and [4]PR33+, Figure 5b/c. Both systems showed significant upfield shifting of the Ha
ortho proton of the pyridinium (0.43 ppm for [4]PR23+, 0.42 ppm for [4]PR33+) and
almost no shifting of the Hb meta protons. As before, the highest upfield shift observed
in the alkyl chains is for the Į-protons (0.33 ppm for [4]PR23+ and 0.25ppm for
[4]PR33+), with smaller shifts observed for the protons nearing the terminus. The
terminal methyl protons in both cases show only a small shift of ca. 0.05 ppm,
suggesting that the alkyl chain has passed through the macrocycle and the terminal
group is not encapsulated.
While there is clear indication of [4]pseudorotaxane formation by ESI-MS for
the octyl-appended L43+, the chemical shifts observed by 1H NMR are somewhat
smaller than was observed for the pseudorotaxanes with the shorter alkyl-chain species
L1-L33+. The strongest upfield shifts correspond to the ortho proton (Ha) associated
with the pyridinium moieties, and the Į-protons (Hi) of the octyl group which appear at
8.92 and 4.62 ppm respectively in the free axle and 8.76 and 4.49 ppm in the [4]PR43+
assembly, Figure 5d. The ȕ-protons (Hj) of the octyl chains show very little shifting and
there are no significant shifts through the rest of the chain. Overall, it is evident that the
shorter chain axles (L13+-L33+) exhibit much larger proton shifts than the longer octyl
appended axle L43+. This may be due to the additional flexibility of the octyl chain
resulting in weaker binding due to more degrees of freedom being inhibited on
threading, or an increased degree of fluxionality of the DMP along the alkyl chain.
13
Figure 5: 1H NMR (300 MHz) studies for the formation of PF6- salts of pseudorotaxanes
[4]PR13+-[4]PR43+: (a) {(DMP)3ÂL1)}3+ (= [4]PR13+) upper spectrum and L13+ lower
spectrum; (b) {(DMP)3ÂL2)}3+ (= [4]PR23+) upper spectrum and L23+ lower spectrum;
(c) {(DMP)3ÂL3)}3+ (= [4]PR33+) upper spectrum and L33+ lower spectrum; (d)
{(DMP)3ÂL4)}3+ (= [4]PR43+) upper spectrum and L43+ lower spectrum. In all cases
signals from DMP are denoted by asterisks (*).
2D NMR experiments were also conducted on the pseudorotaxane species.
Weak through-space interactions were observed for all the pseudorotaxanes in the
14
NOESY spectra; the NOESY spectrum of [4]PR13+ (={(DMP)3ÂL1)}3+ ) is shown in
Figure 6. Weak interactions are observed between the Hi ortho protons on the pyridyl
ring of the axle (a) and the aromatic DMP protons (H1). Further weak coupling is also
seen between the terminal ethyl protons (Hh) and the methoxy protons on DMP (H3).
NOESY spectra for the other pseudorotaxanes [4]PR23+ - [4]PR43+ are shown in the
supplementary material. Literature values for association constants for 1:1 complexes of
DMP with alkylated pyridinium guest species are consistently ca. 1-2 x 103 M-1.8,12
Given these modest expected binding constants and the symmetrical nature of the NMR
spectra a mixture of [2]-, [3]- and [4]-pseudorotaxanes species may exist in solution and
these are likely to be in rapid exchange on the NMR timescale.
15
Figure 6. NOESY spectrum of [4]PR13+ in d3-MeCN/CDCl3 showing through-space
interactions between axle L13+ and DMP at three points.
Attempts to crystallise the [4]pseudorotaxanes were unsuccessful as changes to
solvent composition through slow evaporation invariably led to the crystallisation of
dimethoxypillar[5]arene, which is only sparingly soluble in the acetonitrile co-solvent.
16
An energy-minimised structure of the [4]pseudorotaxane [4]PR23+ was therefore
calculated to shed light on the assembled structure. This model shows that the three
pseudorotaxane associations fit well with the minimised L23+ structure, with no steric
clashes with either themselves or the ligand, Figure 7. The most favourable binding sites
for the macrocycles are located directly over the cationic nitrogen of the pyridinium
arms with the methoxy-groups at both ends of the macrocycle residing either side of the
nitrogen position so to best interact with this electron-poor donor. The structure shows
approximate C3-symmetry with each N-propyl-isonicotinonyl arm extended away from
the cavity and each DMP macrocycle threading parallel to the S-system of the
pyridinium unit on each arm. This is in keeping with the 1H NMR studies where the
strongest upfield shifts suggest that the electron-poor pyridinium group and the D-CH2
of the alkyl chain are enveloped within the electron-rich macrocycle.
Figure 7. Energy-minimised structure of {(DMP)3ÂL2)}3+ (= [4]PR23+).
17
Experimental
Synthesis
Dimethoxypillar[5]arene (DMP) 8 and (±)-tris(isonicotinoyl)cyclotriguaiacylene 20 were
synthesised by literature methods. All other chemicals were obtained from commercial
sources and were used without further purification. 1H NMR spectra were recorded by
automated procedures on a Bruker DPX 300 MHz NMR spectrometer. Electrospray
mass spectra (ES-MS) were measured on a Bruker Maxis Impact instrument in positive
ion mode. Infra-red spectra were recorded as solid phase samples on a Bruker ALPHA
Platinum ATR. Elemental analyses were performed on material that had been washed
ZLWKGLHWK\OHWKHUVXEVHTXHQWO\GULHGDWÛ&XQGHUYDFXXPDQGWKHQH[SRVHGWR
the atmosphere.
(±)-Tris-(NHWK\OLVRQLFRWLQR\OF\FORWULJXDLDF\OHQHKDOLGH/Â;(±)-Tris-
(isonicotinoyl)cyclotriguaiacylene (400 mg, 0.55 mmol) and potassium iodide (ca. 60
mg) were added to acetonitrile (65 ml). Bromoethane (2 ml, excess) was added and the
mixture heated under reflux with stirring at 95 oC for 88 hours. The resulting orange
solution and suspension was filtered, and the solid washed with ether. The solid was
extracted into minimal nitromethane, forming a yellow solution and leaving white
potassium iodide behind. The solid was removed by filtration and ether was added
slowly to the filtrate to induce precipitation. The solution was left to precipitate in the
freezer, and the solid L1Â;; %URU,FROOHFWHGE\ILOWUDWLRQDVD\HOORZSRZGHU
mg, 0.40 mmol, 73%). HR-MS (ES+) m/z 270.1129 (3+), C48H48N3O93+ requires
270.1125. 1H NMR (300 MHz, dimethylsulfoxide-d6įGJ = 7.0 Hz, 6H, Ha),
8.70 (d, J = 6.8 Hz, 6H, Hb), 7.67 (s, 3H, Hc), 7.37 (s, 3H, Hd), 4.97 (d, J = 13.3 Hz, 3H,
He), 4.80 (q, J = 7.2 Hz, 6H, Hi), 3.79 (d, 3H, Hf) overlapped with 3.76 (s, 9H, Hg), 1.60
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(t, J = 7.3 Hz, 9H, Hh). 13C NMR (75 MHz, dimethylsulfoxide-d6į& 2
(pyridyl C para to N), 146.5 (pyridyl C ortho to N), 142.3 (quaternary aryl CTG), 139.4
(quaternary aryl CTG), 137.2 (quaternary aryl CTG), 132.0 (quaternary aryl CTG),
127.7 (pyridyl meta to N), 123.8 (aryl CTG C-H), 114.6 (aryl CTG C-H), 57.1
(CH2CH3), 56.4 (OCH3), 34.9 (HCH), 16.3 (CH2CH3). FT-IR (cm-1): 3113 (aromatic C-
H), 3039 - 2937 (alkane C-H), 1742 (s, n) (C=O), 1642, 1615, 1575, 1508, 1457, 1400,
1324, 1281 (s, b) (aromatic C-N), 1205, 1178, 1138, 1115, 1070 (m, n) (C-O ester),
1047, 1004, 971, 941, 925, 866, 816, 798, 766, 743, 716, 702, 683, 660, 630, 616, 501,
454. Elemental analysis indicates isolated salt contains I-, calculated for C48H48N3O9I3
(%): C 48.38, H 4.06, N 3.53. Found: C 47.8, H 4.60, N 3.40.
(±)-Tris-(NHWK\OLVRQLFRWLQR\OF\FORWULJXDLDF\OHQHKH[DIOXRURSKRVSKDWH/Â3)6
L1Â;PJZDVGLVVROYHGLQZDWHUPO$PPRQLXPKH[DIOXRURSKRVSKDWH
mg, excess) was added to exchange the halide ions resulting in oil formation. The oil
was triturated for 10 minutes to give a very fine yellow solid, which was collected by
filtration (80 mg, 0.064 mmol, 77 %). 1H NMR (300 MHz, acetonitrile-d3įGJ =
6.9 Hz, 6H, Ha), 8.54 (d, J = 6.6 Hz, 6H, Hb), 7.41 (s, 3H, Hc), 7.15 (s, 3H, Hd), 4.91 (d,
J = 13.8 Hz, 3H, He), 4.65 (q, J = 7.3 Hz, 6H, Hi), 3.76 (d, J = 13.3 Hz, 3H, Hf), 3.76 (s,
9H, Hg), 1.61 (t, J = 7.3 Hz, 9H, Hh). Elemental analysis, calculated for
C48H48N3O9P3F18.2H2O (%): C 44.98, H 4.09, N 3.28. Found: C 44.83, H 3.54, N 3.43.
(±)-Tris-(NSURS\OLVRQLFRWLQR\OF\FORWULJXDLDF\OHQHKH[DIOXRURSKRVSKDWH/Â3)6
(±)-Tris(isonicotinoyl)cyclotriguaiacylene (200 mg, 0.28 mmol), potassium iodide (30
mg, 0.2 mmol) and 1-bromopropane (3 ml, excess) were added to N,N’-
dimethylformamide (DMF, 10 ml). The mixture was heated at 120 oC with stirring for
60 hours. The reaction was then cooled to room temperature, and water (20 ml) was
19
added to precipitate the crude product as a yellow solid. This was collected and
redissolved in acetonitrile (10 ml) and a saturated solution of ammonium
hexafluorophosphate (182 mg, 1.1 mmol, 4 eq.) was added dropwise to the stirred
solution giving L2Â3)6 as an orange solid (255 mg, 0.19 mmol, 69 %). HR-MS (ES+)
m/z 1142.3138. C51H54N3O9P2F6+ requires 1142.3127. 1H NMR (300 MHz, acetonitrile-
d3įGJ = 6.6 Hz, 6H, Ha), 8.56 (d, J = 6.0 Hz, 6H, Hb), 7.43 (s, 3H, Hc), 7.18 (s,
3H, Hd), 4.91 (d, J = 13.8 Hz, 3H, He), 4.60 (t, J = 7.2 Hz, 6H, Hi), 3.78 (m, 12H, Hf/g),
2.04 (q, J = 7.5 Hz, 6H, Hj), 0.99 (t, J = 7.5 Hz, 9H, Hh). 13C NMR (75 MHz, DMSO-
d6į& 2S\ULG\O&para to N), 146.6 (pyridyl C ortho to N), 142.4
(quaternary aryl CTG), 139.4 (quaternary aryl CTG), 137.2 (quaternary aryl CTG),
132.0 (quaternary aryl CTG), 127.8 (pyridyl meta to N), 114.6 (aryl CTG C-H), 62.7
(CH2ĮWR12&+3), 35.0 (HCH), 24.3 (CH2ȕWR1&+2CH3). FT-IR (cm-
1): 1754, 1645, 1615 (C-N), 1580, 1507, 1461, 1400, 1328, 1279, 1207, 833 (P-F).
Elemental analysis, calculated for C51H54F18N3O9P3 (%): C 47.67, H 3.99, N 3.33.
Found: C 47.56, H 4.23, N 3.26.
(±)-Tris-(NEXW\OLVRQLFRWLQR\OF\FORWULJXDLDF\OHQHKH[DIOXRURSKRVSKDWH/Â3)6
(±)-Tris(isonicotinoyl)cyclotriguaiacylene (200 mg, 0.28 mmol), potassium iodide (30
mg, 0.2 mmol) and 1-bromobutane (3 ml, excess) were added to DMF (10 ml), and
heated at 120 oC with stirring for 60 hours. The reaction was then cooled to room
temperature, and water (20 ml) was added to precipitate the crude product as a yellow
solid. This was redissolved in acetonitrile (10 ml) and a saturated solution of
ammonium hexafluorophosphate (182 mg, 1.1 mmol, 4 eq.) was added dropwise to the
stirred solution to precipitate L3Â3)6 as a brown solid (312 mg, 0.24 mmol, 88 %).
HR-MS (ES+) m/z 298.1437 (3+). C54H60N3O93+ requires 298.1438. 1H NMR (300
20
MHz, nitromethane-d3įGJ = 6.8 Hz, 6H, Ha), 8.53 (d, J = 6.6 Hz, 6H, Hb), 7.41
(s, 3H, Hc), 7.15 (s, 3H, Hd), 4.92 (d, J = 13.8 Hz, 3H, He), 4.60 (t, J = 7.5 Hz, 6H, Hi),
3.76 (s, 3H, Hf), 3.76 (s, 9H, Hf), 1.92 (p, J = 6 Hz, overlap with d3-MeCN, 6H, Hg),
1.37 (h, J = 7.3 Hz, 6H, Hk), 0.95 (t, J = 7.3 Hz, 9H, Hh). 13C NMR (75 MHz,
nitromethane-d3į& 2S\ULG\O&para to N), 145.7 (pyridyl C ortho to
N), 144.2 (quaternary aryl CTG), 139.6 (quaternary aryl CTG), 137.8 (quaternary aryl
CTG), 132.1 (quaternary aryl CTG), 128.2 (pyridyl meta to N), 123.6 (aryl CTG C-H),
114.4 (aryl CTG C-H), 62.9 (CH2ĮWR12&+3), 35.3 (HCH), 33.0 (CH2ȕWR1
19.0 (CH2CH2CH3), 12.3 (CH2CH3). FT-IR (cm-1): 3021 - 2715 (C-H), 1752 (w, n)
(C=O), 1685, 1608, 1537, 1505, 1450, 1403, 1385, 1370, 1335, 1281 (m, b) (aromatic
C-N), 1206, 1176, 1136, 1099, 1068 (w, n) (C-O ester), 1032, 1003, 830 (s, b) (PF6
stretch), 761, 738, 682, 634, 584, 556 (s, n) (PF6 bend), 531, 506. Elemental analysis
indicates C54H60N3O9P4F24.0.5MeNO2 (%): C48.11, H 4.56, N 3.60. Found: C 47.73, H
4.10, N 3.38.
(±)-Tris-(NRFW\OLVRQLFRWLQR\OF\FORWULJXDLDF\OHQHKH[DIOXRURSKRVSKDWH/Â3)6
(±)-Tris(isonicotinoyl)cyclotriguaiacylene (500 mg, 0.69 mmol) and potassium iodide
were added to DMF (6 ml), and 1-bromooctane (2 ml, 10.6 mmol, 16 eq.) was added
and the solution was heated at 100 oCwith stirring for 60 hours. The orange solution
was precipitated with water and excess 1-bromooctane (a colourless oil) was decanted
off and the resultant orange wax was re-dissolved in acetonitrile (10 ml) and excess
solid NH4PF6 was added which induced the precipitation of an orange wax. The wax
was dissolved in acetonitrile (10 ml) and was added to water (50ml) and extracted with
CHCl3 (3 x 50 ml). The organic layers were combined and evaporated. The solid was
triturated in methanol (10 ml) and collected by filtration under suction and washed with
ether to remove residual 1-bromooctane and leave the product as a pale yellow powder
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(612 mg, 0.41 mmol, 59 % after salt exchange). HR-MS (ES+) m/z 354.2058 (3+).
C66H84N3O93+ requires 354.2064. 1H NMR (300 MHz, nitromethane-d3įGJ = 9
Hz, 6H, Ha), 8.56 (d, J = 9 Hz, 6H, Hb), 7.48 (s, 3H, Hc), 7.19 (s, 3H, Hd), 4.93 (d, J =
15 Hz, 3H, He), 4.62 (t, J = 9 Hz, 6H, Hi), 3.80 (d, 3H, Hf) overlapped with 3.80 (s, 9H,
Hf), 2.01 (m, 6H, Hj), 1.35 (m, 30H, Hk-o). 0.89 (t, J = 6 Hz, 9H, Hh). 13C NMR (75
MHz, nitromethane-d3į& 2S\ULG\O&para to N), 146.1 (pyridyl C
ortho to N), 144.0 (quaternary aryl CTG), 139.6 (quaternary aryl CTG), 137.8
(quaternary aryl CTG), 132.0 (quaternary aryl CTG), 128.1 (pyridyl meta to N), 123.6
(aryl CTG C-H), 114.4 (aryl CTG C-H), 62.8 (CH2ĮWR12&+3), 35.3 (HCH),
31.4 (CH2ȕWR1RFW\O&+2), 25.6 (octyl CH2), 22.3 (octyl CH2), 13.1
(CH2CH3). FT-IR (cm-1): 3118 - 3031 (aromatic C-H), 2926 - 2853 (alkane C-H), 1750
(s, n) (C=O), 1641, 1615, 1574, 1507, 1460, 1400, 1325, 1270 (s, b) (aromatic C-N),
1206, 1178, 1138, 1103, 1069 (m, n) (C-O ester), 1048, 1004, 924, 872, 816, 765, 744,
720, 682, 661, 639, 629, 547, 508. Elemental analysis calculated for C66H84N3O9P3F18
(%): C 52.91, H 5.65, N 2.80. Found: C 53.00, H 5.70, N 2.70.
[4]Pseudorotaxane formation
General procedure: Dimethoxypillar[5]arene (DMP) dissolved in CDCl3 was added to a
solution of a (±)-tris(N-alkyl-isonicotinoyl)cyclotriguaiacylene hexafluorophosphate
dissolved in an equal quantity of d3-acetonitrile with gentle heating to ensure dissolution
of the DMP. 1H NMR and ESI-MS data were collected on the cooled solutions.
{(DMP)3Â/`Â3)6 (= >@35Â3)6). 1H NMR (300 MHz, CD3CN:CDCl3įV
6H, Hb), 8.45 (d, J = 6 Hz, 6H, Ha), 7.36 (s, 3H, Hc), 7.11 (s, 3H, Hd), 6.84 (s, 10H, aryl-
DMP), 4.88 (d, J = 15.0 Hz, 3H, He), 4.44 (q, J = 6.0 Hz, 6H, Hi), 3.77 (m, 12H, Hf, Hg)
3.70 (s, 30H, DMP-methoxy), 3.67 (s, 10H, CH2-DMP), 1.49 (t, J = 9.0 Hz, 9H, Hh)
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ppm. High-resolution Electrospray Mass spectrometry of CD3CN/CDCl3 solution of 1:3
L1Â3)6 and DMP, showing formation of [4]PR13+ at m/z 1020.7910 (calc 1020.7873),
along with {(DMP)2ÂL1.PF6}2+ at m/zFDOF^'03ÂL1.PF6}2+
at m/zFDOF^'03ÂL1}3+ at m/z 520.5610 (calc 520.5604) and
L13+ at m/z 270.1141 (calc 270.1125).
{(DMP)3Â/`Â3)6 (= >@35Â3)6).1H NMR (300 MHz, CD3CN:CDCl3įGJ
= 6.0 Hz, 6H, Hb), 8.47 (d, J = 6.0 Hz, 6H, Ha), 7.35 (s, 3H, Hc), 7.10 (s, 3H, Hd), 6.83
(s, 10H, aryl-DMP), 4.87 (d, J = 12.0 Hz, 3H, He), 4.28 (t, J = 6.0 Hz, 6H, Hi), 3.76 (m,
12H, Hf, Hg) 3.69 (s, 30H, DMP-methoxy), 3.67 (s, 10H, CH2-DMP), 1.79 (m, 6H, CH2
Hj), 0.92 (t, J = 6.0 Hz, 9H, Hh) ppm. Mass spectrometry of CD3CN/CDCl3 solution of
1:3 L2Â3)6 and DMP, showing formation of [4]PR23+ at m/z 1035.1386 (calc
1035.1374), {[4]PR2Â3)6}2+ at m/z 1625.1895 (calc 1625.1885), along with L23+ at m/z
284.1265 (calc 284.1281) and L2.PF6 2+ at m/z 498.6754 (calc 498.6739).
{(DMP)3Â/`Â3)6 (= >@35Â3)6). 1H NMR (300 MHz, CD3CN:CDCl3įGJ
= 6.0 Hz, 6H, pyridyl meta to N), 8.49 (d, J = 6.0 Hz, 6H, pyridyl ortho to N), 7.38 (s,
3H, aryl CTG), 7.12 (s, 3H, aryl CTG), 6.85 (s, 10H, aryl-DMP), 4.87 (d, J = 12.0 Hz,
3H, HCH), 4.37 (t, J = 6.0 Hz, 6H, CH2ĮWR1P++f, Hg) 3.71 (s, 30H,
DMP-methoxy), 3.68 (s, 10H, CH2-DMP), 1.79 (m, 6H, CH2ȕWR1P+
CH2CH2CH3), 0.94 (t, J = 6.0 Hz, 9H, CH2CH3) ppm. High-resolution Electrospray
Mass spectrometry of CD3CN/CDCl3 solution of 1:3 L3Â3)6 and DMP, showing
formation of [4]PR33+ at m/z 1049.1565 (calc 1049.1531), along with {(DMP)2ÂL3}3+ at
m/z 798.7068 (calc 798.7052) and L33+ at m/z 298.1469 (calc 298.1438).
{(DMP)3Â/`Â3)6 (= >@35Â3)6). 1H NMR (300 MHz, CD3CN:CDCl3įGJ
= 9.0 Hz, 6H, Ha), 8.54 (d, J = 6.0 Hz, 6H, Hb), 7.36 (s, 3H, Hc), 7.11 (s, 3H, Hd), 6.86
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(s, 10H, aryl-DMP), 4.89 (d, J = 13.6 Hz, 3H, He), 4.49 (t, J = 7.4 Hz, 6H, Hi), 3.79
(12H, m, Hf, Hg), 3.73 (30H, s, OMe-DMP), 3.70 (10H s, CH2-DMP), 2.09 (6H, m, Hj),
1.33 (m, 12H, Hk-o), 0.88 (9H, t, J = 6.6 Hz, Hh). High-resolution Electrospray Mass
spectrometry of CD3CN/CDCl3 solution of 1:3 L4Â3)6 and DMP, showing formation
of [4]PR43+ at m/z 1105.2059 (calc 1105.2157), along with {(DMP)2ÂL4}3+ at m/z
FDOF^'03ÂL4}3+ at m/z 604.6564 (calc 604.6543), and L43+ at
m/z 354.2083 (calc 354.2064).
Molecular Modelling
The DMP macrocycle was manually placed on each side chain of the cavitand ligand
and energy minimisation was performed using Macromodel 24 and the OPLS_2005
force field. 25 A chloroform solvent environment was used for the minimisation.
X-Ray Crystallography
Crystals were mounted under inert oil on a MiTeGen tip and flash frozen. X-ray
GLIIUDFWLRQGDWDZHUHFROOHFWHGXVLQJV\QFKURWURQUDGLDWLRQȜ cDWVWDWLRQ,
of Diamond Light Source (L1Â3)6), or with Cu-KDUDGLDWLRQȜ cXVLQJDQ
Agilent Supernova dual-source diffractometer with Atlas S2 CCD detector and fine-
focus sealed tube generator (L2Â3)6Â&+3&1Â+2O)). Data were corrected for
Lorenztian and polarization effects and absorption corrections were applied using multi-
scan methods. The structures were solved by direct methods using SHELXS-97 and
refined by full-matrix on F2 using SHELXL-97.26Unless otherwise specified, all non-
hydrogen atoms were refined as anisotropic, and hydrogen positions were included at
geometrically estimated positions. Crystals of L1Â3)6were weakly diffracting. The
refined structure contained significant void space with residual electron density which
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could not be meaningfully modelled as either counter-anions nor solvent, hence the
SQUEEZE routine of PLATON was employed.27 C48H48F18N3O9P3,Mr = 1245.8,
orange needle, 0.15 x 0.10 x 0.03 mm, monoclinic, a = 20.317(13), b = 24.489(17), c =
28.38(2) Å, E = 95.855(8), V = 14044(17) Å3, space group C2/c, Z = 8, ȡcalc = 1.178 g
cm-3; O = 0.68890 Å, Tmax = 24.25 °, 55535 data collected, Rint = 0.051, 547 parameters,
R1 = 0.1448 (for 7415 data I > 2V(I)), wR2 = 0.4499 (all 12238 data), T = 100(1) K.
CCDC-1494001.
For (L2Â3)6Â&+3&1Â+2O) one L23+ cavitand cation was refined with two
disordered group. One propyl group was refined with a methylene disordered across two
positions each at 50% occupancy, and most of one N-propyl-pyridinium disordered over
two positions at 75% and 25% occupancies. Disordered atoms, solvent water and
acetonitrile positions were refined isotropically. C110H124F33N10O20P6, Mr = 2719.01,
yellow prism, 0.20 x 0.11 x 0.06 mm, monoclinic, a = 32.7129(15), b = 20.3327(4), c =
40.5779(17) Å, E= 98.482(4), V = 26694.8(17) Å3, space group C2/c, Z = 8, ȡcalc =
1.353 g cm-3; O = 1.54184 Å, Tmax = 70.00°, 48253 data collected, Rint = 0.0389, 1639
parameters, R1 = 0.1623 (for 14453 data I > 2V(I)), wR2 = 0.4666 (all 20545 data), T =
110(1) K. CCDC-1494000.
Conclusions
Four novel pseudorotaxane systems have been synthesised as confirmed by 1H NMR
spectroscopy and mass spectrometry. These are the first examples of tris-substituted C3-
symmetric pseudorotaxanes formed from functionalised CTG-scaffolds, which
themselves have host-like properties associated with the hydrophobic
[a.d.g]cyclononatriene bowl. The affinity for alkyl-pyridinium units described in this
work to assemble with pillar[5]arenes demonstrates the potential of this system for the
25
design of more complicated molecular machinery by incorporation of competing
binding groups.
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